Contact   |   Login
Human Pharmaceuticals Banner Image

MegaFeed†

MegaFeed™, a manufactured brand of Pharmapex Animal Health Department (AHD), offers the highest quality of specialty products for the animal feed industry around the world. Our products are unique and customized for improving a variety of feed related procedures for Poultry (Breeders, Layers, and Broilers) and Cattle (Dairy and Beef), as well as other species such as Horses, Sheep, Swine, and Fish.

All of our products have been fully researched and certified, as required, by accredited laboratories in the United States such as Romer Labs and Trilogy Analytical Laboratories. Our ingredients are approved by U.S. Food and Drug Administration (FDA) and the American Association of Feed Control Officials (AAFCO).

MegaFeed™ family of products, which have commercially proven to be very effective in the field, includes the following additives:



†We manufacture many of our products under distinct brand names for sales and distribution in different parts of the world. This assignment of brand names to different territories and our strategic brand management are carried out based on various factors including our corporate polices, global and regional marketing strategies, distributorship arrangements, and product customization. For information about availability of specific brands in your country you may contact our Marketing Department at marketing@pharmapexgroup.com.


Quick Contact

Press Releases and Selected News:
Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.
Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.
FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.